Vivo Capital portfolio
58 tracked investments, 8 on the map, $860.2M raised across the mapped portfolio.
- Compass PathwaysPost-IPO Equity
- SCIENTIA VASCULARPrivate Equity
- Ossium HealthSeries C
- Sera PrognosticsSeries E
- Kadmon, a Sanofi CompanyPost-IPO Equity
- ADARx PharmaceuticalsSeries C
- Tarsus PharmaceuticalsSeries B
- Impel Pharmaceuticals
Also in the portfolio
- Ajax Therapeutics
- CAMP4 Therapeutics
- BlossomHill Therapeutics
- Terns Pharmaceuticals
- Compass Therapeutics
- Design Therapeutics
- EpiBiologics
- Bristol-Myers Squibb
- Akari Therapeutics
- Revolution Medicines
- Zai Lab
- Neocis
- Aligos Therapeutics
- PatientPop
- ORIC Pharmaceuticals
- Cidara Therapeutics
- Ascendis Pharma
- Attralus
- KALA BIO
- Bonum Therapeutics
- Surrozen
- Pulmocide
- Abeona Therapeutics
- Cerebral Therapeutics
- ALX Oncology
- INBRACE
- Avadel Pharmaceuticals
- Pasithea Therapeutics
- Innocare
- Revance Therapeutics
- Aerobiotix
- Amyris
- Outpost Medicine
- Delcath Systems
- Sierra Oncology
- Regulus Therapeutics
- Sinovac Biotech
- IGM Biosciences
- Tricida
- Neurogastrx
- ESSA Pharma
- CAPNIA
- Sagent Pharmaceuticals
- Angiotech Pharmaceuticals
- Synapse Biomedical
- Copernicus Therapeutics
- Cotherix
- Transcept Pharmaceuticals